BioSpace News Archive

Rapid improvements have been seen in acutely ill patients with COVID-19 treated with the cancer drug acalabrutinib (Calquence) by researchers, including physicians within The US Oncology Network (The Network).

The PolyPeptide Group, a global Contract Development and Manufacturing Organization (CDMO) for Peptide, Peptidomimetic and other Drug Substances, has announced that it has partnered with Novavax Inc. (NASDAQ: NVAX),

Apotex is expanding the previously announced Retail Level recall of Metformin Hydrochloride Extended-Release Tablets, USP 500mg that was initiated on May 29, 2020 to Consumer Level.

Medicare beneficiaries have the right to receive quality healthcare, whether they are receiving routine care or actively being treated for an acute condition. During the COVID-19 pandemic, Livanta’s resources make it easy for patients and their caregivers to find help in addressing their healthcare concerns.

Apellis Pharmaceuticals, Inc., a global biopharmaceutical company pioneering targeted C3 therapies, announced that the company approved the grant of equity awards to four new employees with a grant date of June 1, 2020, as an equity inducement award outside of the company’s 2017 Stock Incentive Plan and material to the employees’ acceptance of employment with the company.

Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology both in vivo and ex vivo , today announced the closing of an underwritten public offering of 6,301,370 shares of its common stock, including the exercise in full by the underwriters of their option to purchase an additional 821,917 shares, at the public offering price of $18.25 per share. The

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that on Monday, June 8, 2020 at 8:30 am Eastern Time (ET), it will host a webcast and conference call to present new data from the ongoing study of SRP-9003, an investigational gene therapy to treat Limb-girdle muscular dystrophy Type 2E, or beta-sarcoglycanopathy. Results will include expression and safety results from the hi

Amgen (NASDAQ:AMGN) will present at the Goldman Sachs 41st Annual Virtual Global Healthcare Conference on Wednesday, June 10, 2020 at 1:20 p.m. ET . Peter H. Griffith , executive vice president and chief financial officer, and David M. Reese , M.D., executive vice president of Research and Development at Amgen will present

Check-Cap Ltd . (the “Company” or “Check-Cap”) (NASDAQ: CHEK), a clinical-stage medical diagnostics company advancing the development of C-Scan ® , the first and only preparation-free ingestible capsule for the prevention of colorectal cancer through the detection of precancerous polyps, today announced that the Company received a let

Proteostasis Therapeutics, Inc. (NASDAQ: PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF), today announced that, due to public health and safety concerns related to the ongoing COVID-19 global pandemic and to support the health and well-bei